March 3 (Reuters) - Pfizer ( PFE ) CEO Albert Bourla
said on Monday the drugmaker might move overseas manufacturing
to the U.S., if required, as President Donald Trump's
administration threatens numerous tariffs on imported goods.
(Reporting by Christy Santhosh in Bengaluru; Editing by Sriraj
Kalluvila)